Sun Pharma approves NCD issue worth up to 100 billion rupees
Sun Pharmaceutical Industries has approved issuing non-convertible debentures with a total value of up to 100 billion rupees.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
According to Newsmetry API, Sun Pharmaceutical Industries Ltd has approved the issuance of non-convertible debentures (NCDs) worth up to 100 billion rupees.
The decision involves raising funds through an NCD issue; the report provides no further details about the transaction’s terms.
why it matters
The approval may affect how investors assess Sun Pharmaceutical Industries’ prospective debt burden and funding structure, although placement terms have not yet been disclosed.
instruments
sources
- Sun Pharma Approves Issuance Of NCDs Worth Up To 100 Billion Rupees — Newsmetry API, 12 October 2026 at 14:28 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗